Microtubules are a component of the cytoskeleton, found throughout the cytoplasm.These highly dynamic tubular tubulin polymers have an average length of 25 m and a maximum growth length of 50 micrometers. A microtubule has an inner diameter of 12 nm and an outer diameter of about 24 nm. Alpha and beta tubulin combine to form a dimer, which is then polymerized to form microtubules, which are found in eukaryotic cells. One of many members of a small family of globular proteins is tubulin.The alpha-, beta-, gamma-, delta-, and epsilon-tubulins are among the five distinct families that make up the tubulin superfamily, and a sixth family is only found in kinetoplastid protozoa. The proteins that make up microtubules, -tubulin and -tubulin, are the most prevalent members of the tubulin family. Microtubules play a crucial role in many cellular processes. They assist in keeping the cell's structure intact.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V34998 | Anticancer agent 98 | 2857070-72-3 | Anticancer agent 98 (compound 12k) is a tubulin polymerization inhibitor (Kd=16.9 μM). |
![]() |
V34829 | Antiproliferative agent-14 | 1885900-35-5 | antiproliferation agent-14 (compound 3b) is a potent inhibitor of tubulin polymerization with IC50 of 3.41 μM. |
![]() |
V78056 | Antiproliferative agent-23 | antiproliferation agent-23 is a microtubule destabilizing agent (MDA) that effectively interferes with the tubulin-microtubule system. | |
![]() |
V55250 | Antiproliferative agent-30 | 2713553-88-7 | antiproliferation agent-30 (Compound 8g) inhibits tubulin assembly and inhibits FLT3 and Abl1. |
![]() |
V79807 | Antitubulin agent 1 | Antitubulin agents-1 is an antitubulin agent that induces disruption of microtubules (Microtubule/Tubulin) and increases α-tubulin acetylation. | |
![]() |
V83574 | Antitumor agent-138 | 2975168-22-8 | |
![]() |
V88701 | Antitumor agent-155 | Antitumor agent-155 (Compound 13) inhibits microtubule polymerization and induces cell autophagy and apoptosis. | |
![]() |
V88697 | Antitumor agent-164 | 2757188-21-7 | Antitumor agent-164 (compound 60c) is a colchicine binding site inhibitor (CBSI) with efficacy in taxane-sensitive TNBC. |
![]() |
V101221 | Antitumor agent-168 | Antineoplastic agent-168 (compound 21b) disrupts the microtubule network in tumor cells, leading to G2/M cell cycle arrest and inducing apoptosis. | |
![]() |
V104595 | APL-1081 | 2921735-80-8 | APL-1081 (Mal-Exo-EVC-MMAE) is part of an antibody-conjugated active molecule ADC. |
![]() |
V5180 | Auristatin E | 160800-57-7 | Auristatin E,a synthetic analog of dolastatin 10, is a novel and highly cytotoxic tubulin inhibitor with antitumor activity; it is a MMAE analog and cytotoxin used in Antibody-drug conjugates. |
![]() |
V52340 | Bis-ANS dipotassium | 65664-81-5 | Bis-ANS dipotassium is a protein fluorescent probe. |
![]() |
V13004 | BNC-105 | 945771-74-4 | BNC105 is a potentbenzofuran-basedtubulin polymerization inhibitor and also avascular disrupting agent (VDA) prodrug with potential anti-vascular and anticancer activities. |
![]() |
V94978 | BNZ-111 | 3022361-60-7 | BNZ-111 is an orally available tubulin inhibitor with anti-tumor activity. |
![]() |
V103501 | BP-M345 | 1360119-00-1 | BP-M345 (compound 5) is a potent cancer cell-targeted antiproliferative agent with low toxicity to non-tumor cells. |
![]() |
V106250 | Breast cancer targeting peptide 18–4 | 1332850-08-4 | Breast cancer targeting peptide 18-4 is a keratin 1 (KRT1) receptor targeting peptide with a Kd of 0.98 μM. |
![]() |
V3229 | BTB-1 | 86030-08-2 | BTB-1 is a novel, potent and the first small molecule inhibitor of the mitotic motor protein Kif18A. |
![]() |
V88615 | CDK2/4-IN-1 | CDK2/4-IN-1 (compound B-4a) is a CDK2/4 inhibitor and also a tubulin polymerization inhibitor. | |
![]() |
V96733 | Cemadotin hydrochloride | 172837-41-1 | Cemadotin hydrochloride (LU103793), a water-soluble synthetic dolastatin 15 analog, inhibits cell proliferation in vitro and growth of mouse tumor xenografts. |
![]() |
V105323 | Cetuximab MMAE | Cetuximab MMAE is an antibody-drug conjugate (ADC) that is an anti-EGFR humanized monoclonal antibody conjugated to VcMMAE. |